[1]刘莉,吴春林,邓小艳,等.IFIT 1和IFITM 3在子宫内膜异位症病灶中的表达研究[J].中国计划生育和妇产科,2020,(9):22-26.
　LIU Li,WU Chunlin,DENG Xiaoyan,et al.Study on the expression of IFIT 1 and IFITM 3 in endometriosis lesions[J].Chinese Journal of Family Planning & Gynecotokology,2020,(9):22-26.
点击复制

IFIT 1和IFITM 3在子宫内膜异位症病灶中的表达研究
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年9期
页码:
22-26
栏目:
论著与临床
出版日期:
2020-09-25

文章信息/Info

Title:
Study on the expression of IFIT 1 and IFITM 3 in endometriosis lesions
作者:
刘莉; 吴春林; 邓小艳; 胡雅君*
武汉市第一医院（武汉市中西医结合医院）生殖医学科
Author(s):
LIU Li;  WU Chunlin;  DENG Xiaoyan;  HU Yajun*
Department of Reproductive Medicine, Wuhan NO.1 Hospital (Wuhan Hospital of Traditional Chinese and Western Medicine), Wuhan Hubei 430000, P.R.China
关键词:
子宫内膜异位症; 异位内膜组织; 在位内膜组织; 干扰素诱导蛋白1; 干扰素诱导跨膜蛋白3
Keywords:
endometriosis; ectopic endometrium; eutopic endometrium; interferoninduced protein with tetratricopetide repeats 1; interferoninduced transmembrane protein 3
分类号:
R 71171
摘要:
目的检测子宫内膜异位症（以下简称内异症）患者异位、在位内膜组织中干扰素诱导蛋白1（interferoninduced protein with tetratricopetide repeats 1，IFIT 1）、干扰素诱导跨膜蛋白3（interferoninduced transmembrane protein 3，IFITM 3）表达，并探究其对子宫内膜间质细胞的增殖作用。方法选取2018年3月至2019年10月于武汉市第一医院就诊并行腹腔镜或开腹手术治疗、术后经病理证实为内异症的患者86例为研究对象，选取其在位内膜及异位内膜组织分别为在位内膜组与异位内膜组；选取同期因子宫肌瘤或宫颈病变行子宫切除术、病理证实为正常子宫内膜的患者74例为对照组。采用实时荧光定量PCR（qRTPCR）法检测组织中IFIT 1 mRNA、IFITM 3 mRNA表达水平，免疫组织化学法检测各组织中IFIT 1、IFITM 3蛋白表达，采用CCK8法检测IFIT 1、IFITM 3在子宫内膜异位间质细胞分裂增殖中的作用；分析内异症患者在位内膜组织、异位内膜组织中IFIT 1 mRNA、IFITM 3 mRNA表达水平相关性。结果内异症异位内膜组中IFIT 1 mRNA、IFITM 3 mRNA表达水平及其蛋白阳性表达率高于内异症在位内膜组和对照组，内异症在位内膜组中IFIT 1 mRNA、IFITM 3 mRNA表达水平及其蛋白阳性表达率高于对照组，差异均有统计学意义（P＜005）；内异症患者在位内膜组织、异位内膜组织中IFIT 1 mRNA、IFITM 3 mRNA表达水平均呈正相关（r=0534、0574，P＜005）；IFIT 1、IFITM 3可促进子宫内膜间质细胞的增殖和分裂，该作用随着IFIT 1、IFITM 3剂量的增加而增强；当IFIT 1、IFITM 3剂量增加到10 μg/L时，其促进子宫内膜间质细胞的增殖和分裂作用是对照组的186和188倍，差异有统计学意义（P＜005）。结论IFIT 1、IFITM 3在内异症异位内膜组织、在位内膜组织中表达明显高于正常子宫内膜组织，且对子宫内膜间质细胞的增殖和分裂有促进作用。
Abstract:
ObjectiveTo detect the expressions of interferoninduced protein with tetratricopetide repeats 1 (IFIT 1) and interferoninduced transmembrane protein 3 (IFITM 3) in ectopic and eutopic endometrium of endometriosis patients, and to explore their effect on the proliferation of endometrial stromal cells.MethodsFrom March 2018 to October 2019,86 patients with endometriosis who were treated by laparoscopy or laparotomy in Wuhan NO.1 Hospital and confirmed by pathology after operation were selected as the study objects, the eutopic endometrium and ectopic endometrium were selected as in eutopic endometrium group and ectopic endometrium group respectively; at the same time, 74 cases of normal endometrium who were treated by hysterectomy due to hysteromyoma or cervical lesions and confirmed by pathology after operation were selected as the control group. The expression levels of IFIT 1 mRNA and IFITM 3 mRNA were detected by realtime fluorescent quantitative PCR (qRTPCR), the protein expressions of IFIT 1 and IFITM 3 was detected by immunohistochemistry, the effects of IFIT 1 and IFITM 3 on the proliferation of endometrial stromal cells were detected by CCK8 method; and the correlation between the expression levels of IFIT 1 mRNA and IFITM 3 mRNA in eutopic and ectopic endometrium of patients with endometriosis was analyzed.ResultsThe expression levels and protein positive rates of IFIT 1 mRNA and IFITM 3 mRNA in ectopic endometrium group were significantly higher than those in eutopic endometrium group and normal control group (P<005), the expression levels and protein positive rates of IFIT 1 mRNA and IFITM 3 mRNA in eutopic endometrium group were significantly higher than those in normal control group (P<005); there was a positive correlation between the expressions of IFIT 1 mRNA and IFITM 3 mRNA in eutopic and ectopic endometrium tissues (r=0534,0574,P<005);IFIT 1 and IFITM 3 can promote the proliferation and division of endometrial stromal cells, and the effect was enhanced with the increases of IFIT 1 and IFITM 3; when the doses of IFIT 1 and IFITM 3 increased to 10 μg/L, their effects of promoting the proliferation and division of endometrial stromal cells were 186 and 188 times higher than those of the control group (P<005).ConclusionThe expressions of IFIT 1 and IFITM 3 in ectopic endometrium tissues and eutopic endometrium tissues of endometriosis are significantly higher than those in normal endometrial tissue, and they can promote the proliferation and division of endometrial stromal cells.

参考文献/References:

［1］Liutkeviciene· R，Mece·jus G，ilovic D，, et al. Endometrial biopsy and density of nerve fibers in eutopic endometrium. Looking for easier ways to diagnose endometriosis ［J］. Gynecological Endocrinology, 2019, 35(12): 11071110. ［2］梁炎春，曾伟婷，吴锦杰，等．HMGB1在子宫内膜异位症神经病理性疼痛中的作用 ［J］．中华妇产科杂志，2018，53（2）：135138． ［3］Hye J C, Jungyoon Y, Tae H K, et al. Overexpression of four joint Box1 protein (FJX1) in eutopic endometrium from women with endometriosis ［J］. Reproductive Sciences, 2018, 25(2): 207213. ［4］黄艳，曾诚，吴培莉，等．异位子宫内膜间质细胞中LIF及IL6对VEGF的调控作用 ［J］．中华妇产科杂志，2019，54（5）：324329． ［5］Pidugu VK,Yen AH,Chen YC,et al.Abstract 3933:characterization of oncogenic activity of interferoninduced protein with tetratricopeptide repeats 1 and 3 in human oral squamous cell carcinoma progression ［J］.Cancer Research,2017,77(13):3933. ［6］冯潜，周勇，石世代，等．AGR2调控IFITM3的表达促进肝癌细胞的增殖 ［J］．世界华人消化杂志，2015，23（10）：15851591． ［7］Min Jiaqi, Hu Junwen, Chen Luo, et al. IFITM3 upregulates cmyc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway ［J］. Bioscience Trends, 2019, 13(6): 523529. ［8］Malvezzi H， Da Broi MG， Meola J， et al. Peritoneal fluid of women with endometriosis reduces SOD1 in bovine oocytes in vitro maturation［J］. Cell and Tissue Research, 2018, 372(3): 621628. ［9］Samadieh Y，Favaedi R，Ramezanali F,et al.Epigenetic dynamics of HOXA10 gene in infertile women with endometriosis ［J］. Reproductive Sciences,2019,26(1):8896. ［10］董千靖，段华，汪沙．肌成纤维细胞在子宫内膜异位症纤维化形成中的作用 ［J］．中华妇产科杂志，2017，52（10）：714716． ［11］Dong Fangzheng,Zhang Qiyao,Wei Kong,et al.Regulation of endometrial cell proliferation by estrogeninduced BDNF signaling pathway ［J］.Gynecological Endocrinology,2017,33(6):485489. ［12］Pingale K D, Gayatri D K, Yogesh A K. Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1mediated translation inhibition ［J］. Journal of General Virology, 2019, 100(3): 471483. ［13］Feng Bo, Zhang Qian, Wang Jianfang, et al. IFIT1 expression patterns induced by H9N2 virus and inactivated viral particle in human umbilical vein endothelial cells and bronchus epithelial cells ［J］. Molecules and Cells, 2018, 41(4): 271281. ［14］Pidugu V K, Meeimaan W, Aihsin Y, et al. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the antitumor effect of gefitinib via enhancing pEGFR recycling ［J］. Oncogene, 2019, 38(17):32323247. ［15］Zhang Jinfeng,Yao Chen,Lin Guoshi,et al. High IFIT1 expression predicts improved clinical outcome,and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma ［J］. Human Pathology,2016,52(1):136144. ［16］代晓楠，吕金燕，翁文采，等．肝癌组织IFITM3蛋白表达水平及其与肝细胞癌患者手术切除术后肝内肿瘤复发的相关性分析［J］．实用肝脏病杂志，2019，22（1）：117120． ［17］Alam U，Kennedy D. G3BP1 and G3BP2 regulate translation of interferonstimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7 ［J］. Molecular and Cellular Biochemistry, 2019, 459(1/2): 189204. ［18］刘健新，彭斐，任旭皎，等．IFITM3对羊口疮病毒在羊胚胎鼻甲上皮细胞上增殖的影响 ［J］．中国兽医学报，2019，39（7）：12841290． ［19］Lau S L, Manleuk Y, Kou C Y, et al. Interferons induce the expression of IFITM1 and IFITM3 and suppress the proliferation of rat neonatal cardiomyocytes ［J］. Journal of Cellular Biochemistry, 2012, 113(3): 841847. ［20］Pidugu V K, Meeimaan W, AiHsin Y, et al. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the antitumor effect of gefitinib via enhancing pEGFR recycling ［J］. Oncogene, 2019, 38(17): 32323247.

相似文献/References:

[1]苏慧明,徐燕,李晶,等.E-钙粘附素在子宫内膜异位症盆腔腹膜病灶的表达[J].中国计划生育和妇产科,2010,(01):0.
　SU Hui-ming,XU Yan,LI Jing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(9):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]韦晓娜,覃红萍.孕三烯酮配伍小剂量米非司酮治疗子宫内膜异位症64例效果观察[J].中国计划生育和妇产科,2010,(04):0.
[4]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]关铮.深部浸润型子宫内膜异位症相关问题探讨[J].中国计划生育和妇产科,2011,(04):0.
[6]张瑞霞,刘增娟,谢伟,等.腹腔镜诊断盆腔子宫内膜异位症及对不孕症患者的疗效观察[J].中国计划生育和妇产科,2012,(02):0.
　ZHANG Rui-xia,LIU Zeng-juan,XIE Wei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[7]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
　LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[8]范俊,栾少红,李晓林,等.口服避孕药在子宫内膜异位症治疗中的作用[J].中国计划生育和妇产科,2013,(02):0.
　FAN Jun,LUAN Shao-hong,LI Xiao-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(9):0.
[9]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[10]李素红,冯春蝶,付秀虹,等.Treg细胞及Foxp3在子宫内膜异位症患者的表达及临床意义[J].中国计划生育和妇产科,2014,(04):0.
　LI Su-hong,FENG Chun-die,FU Xiu-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.

更新日期/Last Update: 2020-09-25